← Back to Search

Ketone Supplement

Ketone Supplementation for Eating Disorders

N/A
Recruiting
Led By Guido Frank, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to study completion, up to 2 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of ketone supplements on eating habits, mood, and anxiety in people with anorexia or bulimia.

Who is the study for?
This trial is for individuals with Anorexia Nervosa, Bulimia Nervosa, or OSFED related to these conditions. Participants must be medically stable and able to communicate in English. They should respond promptly to study messages up to six times a day. People with certain medical conditions, recent substance abuse, significant brain trauma, intellectual disabilities or allergies to the drink's ingredients cannot join.
What is being tested?
The study examines how a Kenetik Ketone Drink affects eating behaviors, mood and anxiety in those with anorexia or bulimia nervosa. It includes initial EEG tests after taking either the ketone drink or placebo on two consecutive days (randomized), followed by two weeks of twice-daily ketone supplementation.
What are the potential side effects?
Potential side effects are not detailed but may include reactions typical of dietary supplements such as digestive discomfort. Specific risks could relate to ingredients like D-BHB and various additives present in the KenetikR drink.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to study completion, up to 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to study completion, up to 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Eating Disorders
Eating Disorders
Weight Change

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ketone SupplementationExperimental Treatment1 Intervention
Subjects will ingest 2 daily doses of Kenetik ketone drink supplementation for 14 days.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,180 Previous Clinical Trials
1,575,006 Total Patients Enrolled
5 Trials studying Bulimia Nervosa
979 Patients Enrolled for Bulimia Nervosa
Guido Frank, MDPrincipal InvestigatorUniversity of California, San Diego
5 Previous Clinical Trials
438 Total Patients Enrolled

Media Library

Kenetik Ketone Drink (Ketone Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05507008 — N/A
Bulimia Nervosa Research Study Groups: Ketone Supplementation
Bulimia Nervosa Clinical Trial 2023: Kenetik Ketone Drink Highlights & Side Effects. Trial Name: NCT05507008 — N/A
Kenetik Ketone Drink (Ketone Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05507008 — N/A
~13 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top